Reduction in tissue iron stores with a new regimen of continuous ambulatory intravenous deferoxamine
- 1 September 1992
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 41 (1) , 61-63
- https://doi.org/10.1002/ajh.2830410112
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia MajorNew England Journal of Medicine, 1990
- SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJORPublished by Elsevier ,1989
- Rapid removal of excessive iron with daily, high-dose intravenous chelation therapyThe Journal of Pediatrics, 1989
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- Prevention of Cardiac Disease by Subcutaneous Deferoxamine in Patients with Thalassemia MajorNew England Journal of Medicine, 1985
- EFFECT OF DOSE, TIME, AND ASCORBATE ON IRON EXCRETION AFTER SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1977